NCT04177823
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Beijing, China
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT05227144
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- James R. Berenson, MD, Inc. West Hollywood, California, United States
- Northside Hospital Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinical Rochester Rochester, Minnesota, United States
NCT02649790
- Conditions
- Acute Myeloid Leukemia (AML), Blood Protein Disorders, Bone Marrow Diseases, +33 more
- Locations
-
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Oncology Institute of Hope and Innovation Pasadena, California, United States
- Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States
- Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) Denver, Colorado, United States
NCT02506959
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03269136
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSD Medical Center - Encinitas Encinitas, California, United States
- UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Hospital) La Jolla, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Goodyear, Arizona, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Indianapolis, Indiana, United States
NCT06610045
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Caregiver Subjective Burden, +14 more
- Locations
-
- PROxy Network, an initiative of PeriPharm inc. Montreal, Quebec, Canada
Completed
Ixazomib Rollover Study
NCT02924272
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Appalachian Regional Healthcare Hazard, Kentucky, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT00719888
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
NCT04304144
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Research Site Stanford, California, United States
- Research Site Detroit, Michigan, United States
- Research Site Cleveland, Ohio, United States